Skip to main content

Table 1 Sample profile

From: Predictive equations for evaluation for resting energy expenditure in Brazilian patients with type 2 diabetes: what can we use?

Variable Overall
(n = 62)
Men
(n = 31)
Women
(n = 31)
p value
Age (years) 63.1 ± 5.2 63.5 ± 5.5 62.6 ± 4.9 0.473a
Duration of diabetes (years)
Ethnicity (white)
11 (1–36)
50 (80.6%)
12 (1–36)
28 (90.3%)
10 (2–30)
22 (71%)
0.493b
0.307a
Weight (kg) 82.1 ± 14.8 89.9 ± 13.8 74.2 ± 11.2 < 0.001a
Height (cm) 164.8 ± 10.3 172.4 ± 7.6 157.2 ± 6.2 < 0.001a
BMI (kg/m2) 30.1 ± 4.0 30.3 ± 3.8 30.0 ± 4.2 0.736a
Fat-free mass (kg) 35.2 ± 11.8 38.6 ± 12.1 31.7 ± 10.7 0.009a
Fat mass (Kg) 29.1 ± 8.8 27.9 ± 9.3 30.3 ± 8.3 0.278a
Physical activity (steps/week) 5522 (1496–18,097) 5190 (1496–18,097) 6011(1941–14,316) 0.288a
Hypertension 62 (100%) 31 (100%) 31 (100%)
Fasting plasma glucose (mg/dL) 153.3 ± 46.2 162.9 ± 45.5 143.8 ± 45.6 0.105a
A1C (%) 7.6 (5.2–12.0) 7.9 (5.9–12.0) 7.2 (5.2–9.2) 0.126b
Total cholesterol (mg/dL) 162.5 ± 40.3 158.0 ± 44.4 171.1 ± 33.7 0.197b
HDL cholesterol (mg/dL) 44.7 ± 13.8 39.8 ± 8.7 52.7 ± 13.8 < 0.001b
Triglycerides (mg/dL) 172 (49–681) 183 (49–681) 157 (68–342) 0.789b
Medications
 Oral antihyperglycemic agents 62 (100%) 31 (100%) 31 (100%)
 Antihypertensive agents 62 (100%) 31 (100%) 31 (100%)
 Hypolipidemic agents 42 (67.7%) 22 (71%) 20 (64.5%) 0.587c
  1. BMI Body mass index; A1C Glycated hemoglobin; HDL High-density lipoprotein
  2. Data presented as median (interquartile range), n (%), or mean ± standard deviation
  3. a Student’s t-test; b Mann–Whitney U test; c Chi-square test
  4. — Chi-square test impossible because 100% of the sample is hypertensive, on hypoglycemic agents, and on antihypertensive agents